MiR-718 represses VEGF and inhibits ovarian cancer cell progression

FEBS Letters

Volumn 588, Issue 12, 2014, Pages 2078-2086

  Leng, Ruobing ^a   Zha, Lang ^a   Tang, Liangdan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; MiR 718; Ovarian cancer; Proliferation; VEGF

Indexed keywords

MICRORNA; MICRORNA 718; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; MIR-718; OVARIAN CANCER; PROLIFERATION; VEGF;

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901415734     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.040     Document Type: Article

References (28)

1. R. Bhattacharya, M. Nicoloso, R. Arvizo, E. Wang, A. Cortez, S. Rossi, G.A. Calin, and P. Mukherjee MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Cancer Res. 69 2009 9090 9095
2. Q. Bi, S. Tang, L. Xia, R. Du, R. Fan, L. Gao, J. Jin, S. Liang, Z. Chen, and G. Xu et al. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF PLoS One 7 2012 e40169
3. S. Carbajo-Pescador, R. Ordonez, M. Benet, R. Jover, A. Garcia-Palomo, J.L. Mauriz, and J. Gonzalez-Gallego Inhibition of VEGF expression through blockade of Hif1alpha and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells Br. J. Cancer 109 2013 83 91
4. B.K. Edwards, M.L. Brown, P.A. Wingo, H.L. Howe, E. Ward, L.A. Ries, D. Schrag, P.M. Jamison, A. Jemal, and X.C. Wu et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment J. Natl. Cancer Inst. 97 2005 1407 1427 (Pubitemid 41520077)
5. U. Eriksson, and K. Alitalo VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies Nat. Med. 8 2002 775 777
6. X. Fan, Y. Liu, J. Jiang, Z. Ma, H. Wu, T. Liu, M. Liu, X. Li, and H. Tang MiR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells Acta Biochim. Biophys. Sin. 42 2010 318 324
7. A. Gadducci, M. Ferdeghini, A. Fanucchi, C. Annicchiarico, B. Ciampi, C. Prontera, and A.R. Genazzani Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome Anticancer Res. 19 1999 1401 1405 (Pubitemid 29257466)
8. S. Ghosh, and P. Maity VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer J. Environ. Pathol. Toxicol. Oncol. 29 2010 17 30
9. Y. Guan, H. Yao, Z. Zheng, G. Qiu, and K. Sun MiR-125b targets BCL3 and suppresses ovarian cancer proliferation Int. J. Cancer 128 2011 2274 2283
10. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, W.T. Creasman, H.Y. Ngan, S. Pecorelli, and U. Beller Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer Int. J. Gynaecol. Obstet. 95 Suppl. 1 2006 S161 S192
11. P. Hu, W. Liu, L. Wang, M. Yang, and J. Du High circulating VEGF level predicts poor overall survival in lung cancer J. Cancer Res. Clin. Oncol. 139 2013 1157 1167
12. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 CA Cancer J. Clin. 58 2008 71 96 (Pubitemid 351521864)
13. H. Kimura, H. Kato, N. Tanaka, T. Inose, A. Faried, M. Sohda, M. Nakajima, Y. Fukai, T. Miyazaki, and N. Masuda et al. Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer Anticancer Res. 28 2008 165 169
14. Y. Kong, P.S. Bai, K.J. Nan, H. Sun, N.Z. Chen, and X.G. Qi Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer Int. J. Colorectal Dis. 27 2012 287 298
15. Z. Li, F. Qi, L. Qi, H. Zhang, M. Chen, L. Wang, and X. Zu VEGF-C as a decision-making biomarker for selected patients with invasive bladder cancer who underwent bladder-preserving radical surgery Arch. Med. Res. 42 2011 405 411
16. B. Liu, X.C. Peng, X.L. Zheng, J. Wang, and Y.W. Qin MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo Lung Cancer 66 2009 169 175
17. F. Loupakis, C. Cremolini, D. Yang, L. Salvatore, W. Zhang, T. Wakatsuki, P. Bohanes, M. Schirripa, L. Benhaim, and S. Lonardi et al. Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab PLoS One 8 2013 e66774
18. H. Luo, B.H. Jiang, S.M. King, and Y.C. Chen Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids Nutr. Cancer 60 2008 800 809
19. J.X. Ma, Y.L. Sun, Y.Q. Wang, H.Y. Wu, J. Jin, and X.F. Yu Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF Oncol. Res. 20 2013 359 368
20. A. Obermair, C. Tempfer, L. Hefler, O. Preyer, A. Kaider, R. Zeillinger, S. Leodolter, and C. Kainz Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer Br. J. Cancer 77 1998 1870 1874 (Pubitemid 28254626)
21. S. Ogawa, T. Kaku, H. Kobayashi, T. Hirakawa, Y. Ohishi, N. Kinukawa, and H. Nakano Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma Cancer Lett. 176 2002 111 118 (Pubitemid 34085076)
22. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, R.A. Burger, R.S. Mannel, K. DeGeest, E.M. Hartenbach, and R. Baergen Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study J. Clin. Oncol. 21 2003 3194 3200 (Pubitemid 46606249)
23. K. Selvendiran, S. Ahmed, A. Dayton, Y. Ravi, M.L. Kuppusamy, A. Bratasz, B.K. Rivera, T. Kalai, K. Hideg, and P. Kuppusamy HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase Mol. Cancer Res. MCR 8 2010 1188 1197
24. K. Sharpe, G.D. Stewart, A. Mackay, C. Van Neste, C. Rofe, D. Berney, I. Kayani, A. Bex, E. Wan, and F.C. O'Mahony et al. The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer Clin. Cancer Res. 19 24 2013 6924 6934
25. A.R. van der Bilt, A.G. Terwisscha van Scheltinga, H. Timmer-Bosscha, C.P. Schroder, L. Pot, J.G. Kosterink, A.G. van der Zee, M.N. Lub-de Hooge, S. de Jong, and E.G. de Vries et al. Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model Clin. Cancer Res. 18 2012 6306 6314
26. C.X. Xu, M. Xu, L. Tan, H. Yang, J. Permuth-Wey, P.A. Kruk, R.M. Wenham, S.V. Nicosia, J.M. Lancaster, and T.A. Sellers et al. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog J. Biol. Chem. 287 2012 34970 34978
27. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, J. Wang, R.M. Wenham, D. Coppola, P.A. Kruk, and S.V. Nicosia et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res. 68 2008 425 433 (Pubitemid 351380068)
28. L. Yuan, M.J. Wu, H.Y. Sun, J. Xiong, Y. Zhang, C.Y. Liu, L.L. Fu, D.M. Liu, H.Q. Liu, and C.L. Mei VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury Am. J. Physiol. Renal Physiol. 300 2011 F207 218